BioGPS
  • Home
  • Help
  • Plugins
  • Datasets
  • Sign Up
  • Login
Examples: Gene Symbol(s), Gene Ontology, Splicing plugins, Melanoma datasets
advanced
Home › Dataset Library › CD99 is a novel prognostic stromal marker in non-small cell lung cancer

Dataset: CD99 is a novel prognostic stromal marker in non-small cell lung cancer

The delicate interaction between cancer cells and the surrounding stroma plays an essential role in all stages of tumourigenesis. Despite...

Registered by ArrayExpress Uploader
View Dataset

The delicate interaction between cancer cells and the surrounding stroma plays an essential role in all stages of tumourigenesis. Despite the significance of this interplay, alterations in protein composition underlying tumour-stroma interactions are largely unknown. The aim of this study was to identify stromal proteins with clinical relevance in non-small cell lung cancer. A list encompassing 203 stromal candidate genes was compiled based on gene expression array data and available literature. The protein expression of these genes in human NSCLC was screened utilising the Human Protein Atlas. Twelve proteins were selected that showed a differential stromal staining pattern. The corresponding antibodies were applied on a tissue microarray, including 190 NSCLC samples, and stromal staining was correlated with clinical parameters. Higher stromal expression of CD99was associated with good prognosis in the univariate (p=0.037) and multivariate (p=0.039) analyses. The association was independent from the total proportion of tumour stroma, the fraction of inflammatory cells, and clinical and pathological parameters like stage, performance status and tumour histology. The prognostic impact of stromal CD99 protein expression was confirmed in an independent cohort of 240 NSCLC patients (p=0.008). Furthermore, double-staining confocal fluorescence microscopy showed that CD99 was expressed in stromal lymphocytes as well as in cancer associated fibroblasts. Based on a comprehensive screening strategy the membrane protein CD99 was identified as a novel stromal factor with clinical relevance. The result supports the concept that stromal properties have a significant impact on tumourigenesis. Tissue from five tumors were compared to corressponding microdissected tissue from the same tissue sample

Species:
human

Samples:
10

Source:
E-GEOD-33363

PubMed:
22392539

Updated:
Dec.12, 2014

Registered:
Sep.16, 2014


Factors: (via ArrayExpress)
Sample PATIENT ID EXTRACTION ORGANISM PART
GSM825150 1 2µg of total RNA was used to prepare biotinylated fragmented cRNA. non-small cell lung cancer
GSM82515 2 2µg of total RNA was used to prepare biotinylated fragmented cRNA. non-small cell lung cancer
GSM825152 3 2µg of total RNA was used to prepare biotinylated fragmented cRNA. non-small cell lung cancer
GSM825153 4 2µg of total RNA was used to prepare biotinylated fragmented cRNA. non-small cell lung cancer
GSM825154 5 2µg of total RNA was used to prepare biotinylated fragmented cRNA. non-small cell lung cancer
GSM825155 1 20ng of total RNA was used to prepare biotinylated fragmented cRNA using a two-cycle amplification step according to the GeneChip® Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA) microdissected non-small cell lung cancer
GSM825156 2 20ng of total RNA was used to prepare biotinylated fragmented cRNA using a two-cycle amplification step according to the GeneChip® Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA) microdissected non-small cell lung cancer
GSM825157 3 20ng of total RNA was used to prepare biotinylated fragmented cRNA using a two-cycle amplification step according to the GeneChip® Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA) microdissected non-small cell lung cancer
GSM825158 4 20ng of total RNA was used to prepare biotinylated fragmented cRNA using a two-cycle amplification step according to the GeneChip® Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA) microdissected non-small cell lung cancer
GSM825159 5 20ng of total RNA was used to prepare biotinylated fragmented cRNA using a two-cycle amplification step according to the GeneChip® Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA) microdissected non-small cell lung cancer

Tags

  • atlas
  • cancer
  • cell
  • lung
  • lung cancer
  • membrane
  • nsclc
  • protein
  • stroma

Other Formats

JSON    XML
  • About
  • Blog
  • Help
  • FAQ
  • Downloads
  • API
  • iPhone App
  • Email updates
© 2022 The Scripps Research Institute. All rights reserved. (ver 94eefe6 )
  • Terms of Use